User profiles for Sungjune Kim

Sungjune Kim

Associate Member/Professor, H Lee Moffitt Cancer Center
Verified email at moffitt.org
Cited by 3673

Thymopoiesis independent of common lymphoid progenitors

D Allman, A Sambandam, S Kim, JP Miller… - Nature …, 2003 - nature.com
Early T lineage progenitors (ETPs) in the thymus are thought to develop from common lymphoid
progenitors (CLPs) in the bone marrow (BM). We compared thymic ETPs to BM CLPs in …

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

…, C Wang, JK Teer, EM Toloza, J Yao, S Kim… - Nature medicine, 2021 - nature.com
Adoptive cell therapy using tumor-infiltrating lymphocytes (TILs) has shown activity in
melanoma, but has not been previously evaluated in metastatic non-small cell lung cancer. We …

Systematic review of case reports on the abscopal effect

Y Abuodeh, P Venkat, S Kim - Current problems in cancer, 2016 - Elsevier
Radiation therapy is a highly effective local treatment for cancer. However, sporadic events
of tumor regression in unirradiated fields, known as abscopal effect, have been observed for …

[HTML][HTML] Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis

…, SM Schleicher, Y Sun, KJ Niermann, S Kim… - Journal of …, 2011 - hindawi.com
Despite advances in treatment, cancer remains the 2nd most common cause of death in the
United States. Poor cure rates may result from the ability of cancer to recur and spread after …

PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells

VV Parekh, S Lalani, S Kim, R Halder… - The Journal of …, 2009 - journals.aai.org
Invariant NKT (iNKT) cells recognize glycolipid Ags, such as the marine sponge-derived
glycosphingolipid α-galactosylceramide (αGalCer) presented by the CD1d protein. In vivo …

Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial

S Kim, E Wuthrick, D Blakaj, Z Eroglu, C Verschraegen… - The Lancet, 2022 - thelancet.com
Background Merkel cell carcinoma is among the most aggressive and lethal of primary skin
cancers, with a high rate of distant metastasis. Anti-programmed death receptor 1 (anti-PD-1) …

Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice

…, RA Tamboli, S Kim… - Proceedings of the …, 2012 - National Acad Sciences
Obesity triggers a low-grade systemic inflammation, which plays an important role in the
development of obesity-associated metabolic diseases. In searching for links between lipid …

[HTML][HTML] Epigenetic state determines the in vivo efficacy of STING agonist therapy

…, RM Putney, I Hamaidi, S Kim… - Nature …, 2023 - nature.com
While STING-activating agents have shown limited efficacy in early-phase clinical trials,
multiple lines of evidence suggest the importance of tumor cell-intrinsic STING function in …

The future of personalised radiotherapy for head and neck cancer

…, JF Torres-Roca, RJ Gillies, H Enderling, S Kim… - The Lancet …, 2017 - thelancet.com
Radiotherapy has long been the mainstay of treatment for patients with head and neck cancer
and has traditionally involved a stage-dependent strategy whereby all patients with the …

The immune mechanisms of abscopal effect in radiation therapy

GD Grass, N Krishna, S Kim - Current problems in cancer, 2016 - Elsevier
Radiation therapy (RT) is a cornerstone in oncologic management and is employed in various
curative and palliative scenarios for local-regional control. RT is thought to locally control …